1379 related articles for article (PubMed ID: 30828335)
1. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
Campos-Acuña J; Elgueta D; Pacheco R
Front Immunol; 2019; 10():239. PubMed ID: 30828335
[TBL] [Abstract][Full Text] [Related]
2. Brain-gut-microbiota axis in Parkinson's disease.
Mulak A; Bonaz B
World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
[TBL] [Abstract][Full Text] [Related]
3. Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management.
Sharma S; Awasthi A; Singh S
Neurosci Lett; 2019 Nov; 712():134516. PubMed ID: 31560998
[TBL] [Abstract][Full Text] [Related]
4. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V; Giron MC
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Bowel Diseases and Parkinson's Disease.
Brudek T
J Parkinsons Dis; 2019; 9(s2):S331-S344. PubMed ID: 31609699
[TBL] [Abstract][Full Text] [Related]
6. The gut microbiome in Parkinson's disease: A culprit or a bystander?
Keshavarzian A; Engen P; Bonvegna S; Cilia R
Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
[TBL] [Abstract][Full Text] [Related]
7. The immunology of Parkinson's disease.
Zhu B; Yin D; Zhao H; Zhang L
Semin Immunopathol; 2022 Sep; 44(5):659-672. PubMed ID: 35674826
[TBL] [Abstract][Full Text] [Related]
8. Gut brain axis: an insight into microbiota role in Parkinson's disease.
Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M
Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease: Autoimmunity and neuroinflammation.
De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
[TBL] [Abstract][Full Text] [Related]
10. Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease.
Koutzoumis DN; Vergara M; Pino J; Buddendorff J; Khoshbouei H; Mandel RJ; Torres GE
Exp Neurol; 2020 Mar; 325():113159. PubMed ID: 31843492
[TBL] [Abstract][Full Text] [Related]
11. Gut microenvironmental changes as a potential trigger in Parkinson's disease through the gut-brain axis.
Chen SJ; Lin CH
J Biomed Sci; 2022 Jul; 29(1):54. PubMed ID: 35897024
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota-induced CXCL1 elevation triggers early neuroinflammation in the substantia nigra of Parkinsonian mice.
Ma XZ; Chen LL; Qu L; Li H; Wang J; Song N; Xie JX
Acta Pharmacol Sin; 2024 Jan; 45(1):52-65. PubMed ID: 37674043
[TBL] [Abstract][Full Text] [Related]
13. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
[TBL] [Abstract][Full Text] [Related]
14. Gut-to-Brain α-Synuclein Transmission in Parkinson's Disease: Evidence for Prion-like Mechanisms.
Chen M; Mor DE
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108366
[TBL] [Abstract][Full Text] [Related]
15. Gutting the brain of inflammation: A key role of gut microbiome in human umbilical cord blood plasma therapy in Parkinson's disease model.
Lee JY; Tuazon JP; Ehrhart J; Sanberg PR; Borlongan CV
J Cell Mol Med; 2019 Aug; 23(8):5466-5474. PubMed ID: 31148353
[TBL] [Abstract][Full Text] [Related]
16. The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies.
Perez-Pardo P; Kliest T; Dodiya HB; Broersen LM; Garssen J; Keshavarzian A; Kraneveld AD
Eur J Pharmacol; 2017 Dec; 817():86-95. PubMed ID: 28549787
[TBL] [Abstract][Full Text] [Related]
17. Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model.
Dong XL; Wang X; Liu F; Liu X; Du ZR; Li RW; Xue CH; Wong KH; Wong WT; Zhao Q; Tang QJ
Int J Biol Macromol; 2020 Dec; 164():994-1005. PubMed ID: 32710966
[TBL] [Abstract][Full Text] [Related]
18. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
[TBL] [Abstract][Full Text] [Related]
19. Microbiota-mediated effects of Parkinson's disease medications on Parkinsonian non-motor symptoms in male transgenic mice.
Radisavljevic N; Metcalfe-Roach A; Cirstea M; Tabusi MM; Bozorgmehr T; Bar-Yoseph H; Finlay BB
mSphere; 2024 Jan; 9(1):e0037923. PubMed ID: 38078745
[TBL] [Abstract][Full Text] [Related]
20. Implications of the Gut Microbiome in Parkinson's Disease.
Elfil M; Kamel S; Kandil M; Koo BB; Schaefer SM
Mov Disord; 2020 Jun; 35(6):921-933. PubMed ID: 32092186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
